Anika Therapeutics, Inc. (NASDAQ:ANIK)

About the company

Anika Therapeutics, Inc. is an orthopedic and regenerative medicines company, which develops, manufactures and commercializes therapeutic products for pain management, tissue regeneration, and wound healing. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company was founded in 1992 and is headquartered in Bedford, MA.

Sector

Health Technology

Industry

Pharmaceuticals: Other

Employees

154

$125.00M

Total Revenue

154

Employees

$494.90M

Market Capitalization

17.85

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$90M

Operating Margin (in %)

Total operating margin

$29M

Net Margin (in %)

Total net margin

$28M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Horizon Therapeutics Plc HZNP 12018.30 1376.00 5.12 18.95 43.06
Catalent, Inc. CTLT 10896.37 2872.00 5.47 104.47 3.63
Perrigo Co. Plc PRGO 7558.29 4837.00 1.30 51.56 3.02
Jazz Pharmaceuticals Plc JAZZ 6076.20 2188.00 2.10 22.21 12.81
Bausch Health Cos., Inc. BHC 6068.07 8597.00 8.47 -3.21 -21.96
United Therapeutics Corp. UTHR 5049.92 1443.00 1.75 9.75 36.59
MyoKardia, Inc. MYOK 4249.02 34.00 12.35 -13.70 -201.73
Axsome Therapeutics, Inc. AXSM 2906.40 None 19.72 -32.31 None
Pacira Biosciences, Inc. PCRX 2427.60 435.00 6.51 -5780.00 -0.02
ArQule, Inc. ARQL 2240.00 5.00 15.75 -55.56 -808.06
SAGE Therapeutics, Inc. SAGE 2231.84 9.00 2.62 -3.45 -413.06
Corcept Therapeutics, Inc. CORT 2013.00 335.00 4.62 18.97 31.64
Prestige Consumer Healthcare, Inc. PBH 1863.54 963.00 1.57 13.14 14.77
Revolution Medicines, Inc. RVMD 1798.91 48.00 4.67 -25.41 -146.29
Madrigal Pharmaceuticals, Inc. MDGL 1558.65 0.00 4.16 -15.26 -624.74
Ironwood Pharmaceuticals, Inc. IRWD 1548.02 440.00 -21.91 18.26 19.14
Innoviva, Inc. INVA 1520.98 285.00 3.60 7.87 66.41
Intercept Pharmaceuticals, Inc. ICPT 1446.72 272.00 -43.06 -4.22 -127.53
Portola Pharmaceuticals, Inc. PTLA 1329.78 121.00 19.53 -4.77 -232.73
Supernus Pharmaceuticals, Inc. SUPN 1309.50 402.00 2.08 11.23 28.90
Theravance Biopharma, Inc. TBPH 1232.34 88.00 -8.65 -4.99 -280.80
Zogenix, Inc. ZGNX 1225.80 5.00 3.35 -2.88 -241.62
Revance Therapeutics, Inc. RVNC 1161.84 0.00 4.59 -6.23 41.82
Amphastar Pharmaceuticals, Inc. AMPH 996.66 327.00 2.49 19.56 15.90
Endo International Plc ENDP 784.32 3014.00 -1.07 -2.80 -9.09
BellRing Brands, Inc. BRBR 745.68 954.00 -0.40 5.66 13.98
Eagle Pharmaceuticals, Inc. EGRX 678.30 192.00 3.65 269.17 1.29
Assembly Biosciences, Inc. ASMB 667.58 16.00 2.99 -6.71 -601.75
Aerie Pharmaceuticals, Inc. AERI 613.18 79.00 4.86 -3.03 -252.92
Collegium Pharmaceutical, Inc. COLL 582.76 299.00 4.17 -45.11 -4.21
Intersect ENT, Inc. XENT 577.76 102.00 5.45 -11.57 -48.61
Catalyst Pharmaceuticals, Inc. CPRX 528.58 119.00 5.15 12.05 36.09
Anika Therapeutics, Inc. ANIK 494.90 125.00 1.71 17.85 22.73
BioDelivery Sciences International, Inc. BDSI 388.24 130.00 5.55 -52.75 -5.01
Albireo Pharma, Inc. ALBO 326.82 11.00 3.32 -4.28 -730.55
ANI Pharmaceuticals, Inc. ANIP 326.76 203.00 1.67 -209.46 -0.67
MEI Pharma, Inc. MEIP 275.56 5.00 4.74 -7.06 -539.48
Mallinckrodt Plc MNK 199.08 3037.00 0.11 -0.17 -39.56
Agile Therapeutics, Inc. AGRX 147.85 None 2.41 -7.16 None
Marinus Pharmaceuticals, Inc. MRNS 146.79 0.00 5.68 -2.18 None
Cerecor, Inc. CERC 118.22 7.00 7.56 -5.24 -429.22
Ampio Pharmaceuticals, Inc. AMPE 98.67 1.00 69.00 -5.31 None
Evoke Pharma, Inc. EVOK 85.92 None 29.83 -12.79 None
Zynerba Pharmaceuticals, Inc. ZYNE 85.79 0.00 1.41 -2.39 -699.94
AcelRx Pharmaceuticals, Inc. ACRX 84.80 2.00 -1.56 -1.51 -644.25
Aclaris Therapeutics, Inc. ACRS 81.18 4.00 1.42 -0.59 None
Adamas Pharmaceuticals, Inc. ADMS 75.32 57.00 -4.80 -0.81 -160.44
CTI BioPharma Corp. CTIC 71.98 3.00 3.21 -1.74 -111.83
Cassava Sciences, Inc. SAVA 63.46 41.00 3.34 -13.92 76.71
Oramed Pharmaceuticals, Inc. ORMP 59.94 3.00 4.83 -4.69 -464.15
SCYNEXIS, Inc. SCYX 48.28 0.00 10.14 -1.25 -30.84
Cumberland Pharmaceuticals, Inc. CPIX 47.70 47.00 0.97 -10.60 -9.59
Natural Alternatives International, Inc. NAII 47.67 114.00 0.65 -12.61 -3.19
IsoRay, Inc. ISR 44.22 9.00 8.25 -13.20 -36.08
Lipocine, Inc. LPCN 40.20 0.00 9.57 -2.68 None
Acasti Pharma, Inc. ACST 35.84 827.00 2.33 -0.58 -7.45
Neos Therapeutics, Inc. NEOS 34.50 65.00 -2.65 -1.97 -26.74
PLx Pharma, Inc. PLXP 25.65 0.00 -2.46 -2.71 119.04
CytRx Corp. CYTR 22.11 0.00 1.60 -3.19 408.46
EyeGate Pharmaceuticals, Inc. EYEG 19.92 3.00 2.48 -1.68 -264.21
Regulus Therapeutics, Inc. RGLS 17.22 0.00 1.52 -0.80 -272.13
Tetraphase Pharmaceuticals, Inc. TTPH 12.15 8.00 0.64 -0.14 -798.18
Intec Pharma Ltd. NTEC 10.18 None 1.31 -0.24 None
Hepion Pharmaceuticals, Inc. HEPA 7.50 None 2.34 -0.63 None
Sonoma Pharmaceuticals, Inc. SNOA 6.44 19.00 1.02 -2.06 -25.58
KemPharm, Inc. KMPH 6.02 15.00 -0.17 -0.35 -120.48
VIVUS, Inc. VVUS 5.83 73.00 -0.13 -0.20 -39.28
Tonix Pharmaceuticals Holding Corp. TNXP 4.62 None 1.16 -0.10 None
Ritter Pharmaceuticals, Inc. RTTR 0.45 None 0.17 -0.03 None

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Hedge Funds Are Still Bullish On Anika Therapeutics, Inc. (ANIK)

18d ago, source: YAHOO!

Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire ...

ANIK Anika Therapeutics Inc. Common Stock

12d ago, source: Nasdaq

Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is exempt of filing insider holdings ...

Anika Therapeutics Inc.

23d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

“Europe Viscosupplementation Market” to Touch US$ 343.6 Million | 5.0% CAGR during 2020 to 2027 – coherentmarketinsights.com

12d ago, source: Medgadget

Patients suffering from OA have a lower-than-normal concentration of HA in their joints. Injecting HA lubricates bones to ...

Hyaluronic Acid Products Market to Surge at 8% CAGR, Coronavirus Outbreak Might Impact on Growth, Says Market.us

16d ago, source: Benzinga.com

Anika Therapeutics Inc., Smith & Nephew, Shanghai Jingfeng Pharmaceutical Co. Ltd., Salix Pharmaceuticals Ltd. and Sanofi. The Hyaluronic Acid Products market size is projected to expand from ...

Anika Therapeutics PE Ratio (Forward)

23d ago, source: YCharts

Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. The Forward Price to Earnings (PE) Ratio is similar to the price to earnings ratio.

Viscosupplementation Market value to cross USD 5.3 Bn by 2026: Global Market Insights, Inc.

20d ago, source: GlobeNewswire

Global Market Insights, Inc. has recently added a new report on viscosupplementation market which estimates the global market valuation for viscosupplementation will cross US$ 5.3 billion by 2026.



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.